Global Venous Stents Market size reached USD 1,440.6 Million in 2025 and is expected to reach USD 2,987.7 Million through 2034, growing at a CAGR of 11.40% during the forecast period from 2024 to 2034 from 2025 to 2034.
Venous Stents Market Overview
VS are used to treat central and peripheral venous stenosis. Venous injury, inflammation, turbulent flow, and uremia can all play a role in the development of these stenoses. Venous stenoses are particularly troublesome when they are associated with hemodialysis access for a patient with end-stage renal disease.
These stents can treat conditions that obstruct blood flow or induce chronic blood clots in the abdomen, thorax, or legs. Venous stenting is employed as an adjunctive therapy in patients with acute iliofemoral deep vein disease when residual venous occlusion (RVOO) persists following balloon angioplasty and thrombolysis.
The goal is to restore vascular patency and avoid post-thrombotic syndrome (PTS). They are placed within a narrowed or blocked vein and act as scaffolds, keeping the opening of the vein patent and augmenting blood flow.
Venous stenting is a less invasive process that has become increasingly popular as a solution to conditions such as chronic venous insufficiency, deep vein thrombosis, and venous leg ulcers. The process has become more efficient and safe because of developments in stent technology and materials.
Venous Stents Market Growth Factors
Different factors can contribute to the market drivers for the Venous Stents Market. These can include:
The market for venous stents is being fueled by the growing incidence of venous disorders, such as chronic venous insufficiency (CVI), venous ulcers, and deep vein thrombosis (DVT). As the incidence of these conditions grows, venous stents are becoming more and more crucial in managing and treating these conditions.
Venous, more effective and durable stents have been created as a result of continued innovation in stent architecture and material. These innovations improve the radial strength, flexibility, and compression resistance of stents in the venous system, thus prolonging their lifespan and effectiveness.
The venous stent market has been driven by the growing use of minimally invasive techniques in the treatment of venous diseases. The patients prefer these techniques because they are less painful, have shorter recuperation periods, and are less likely to result in complications compared to traditional open procedures.
The need for venous stents is greater because of the higher incidence of venous diseases in the elderly. The incidence of venous ailments and the aging population of the world will probably lead to an increased demand for venous stents.
Venous Stents Market Constraints
There are many factors that can act as barriers or limitations for the Venous Stents Market. These can include:
Inadequate Understanding: Lack of knowledge on the part of patients and healthcare providers about venous disorders and the many available treatments, including the use of venous catheters, is one of the main barriers. This lack of knowledge can result in underdiagnosis and undertreatment of vein disorders.
Cost: The cost of venous stents can severely hinder their utilization, especially in areas where insurance policies might not cover these devices fully. The cost of the stent, along with surgery and follow-up treatment, might be too expensive for certain patients and medical facilities.
Venous Stents Market Recent Developments
Vesper Medical Inc., a medical device company with expertise in designing peripheral vascular devices that need to be implanted with minimally invasive surgery, was acquired by Royal Philips in May 2023. The acquisition brought a product line of advanced venous stents for the treatment of deep vein disease into Philips’ diagnostic and therapeutic portfolio of devices.
August 2020 (Approval): Bentley has received CE marking for its BeYond venous self-expanding stent system, an open cell Nitinol stent indicated for the treatment of acute and chronic symptomatic femoral or iliac occlusions with a diameter of 10-18 mm and a length of up to 150 mm.
Venous Stents Market Regional Analysis
The market for venous stents globally is dominated by Europe and is likely to grow at a compound annual growth rate (CAGR) of 10.3% over the analysis period. The market is likely to grow in Europe as a result of the increasing prevalence of venous diseases.
In Europe, venous stenting safety and efficacy have been improved by employing self-expanding stents, bioresorbable stents, coatings, and drug-eluting stents. Researchers from Oxford University, Imperial College, and the University of Sheffield joined hands with technology firm ThinkSono to create a machine learning AI algorithm (AutoDVT) that was able to distinguish between DVT patients and non-DVT diagnosed patients.
During the forecast period, these trends are expected to enhance market growth. In addition, the venous stents market has witnessed additional growth because of the dramatic rise in the number of minimally invasive venous procedures done for complicated venous diseases over the past few years.